BB1 Acquisition Corp. Enters Into Definitive Agreement with PlantEXT Ltd. to Complete Business Combination
Toronto, Ontario--(Newsfile Corp. - August 19, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1" or the "Company"), a capital pool company as defined under Policy 2.4 - Capital Pool Companies (the "Policy") of the TSX Venture Exchange (the "Exchange"), are pleased to announce that they have entered into a definitive share exchange agreement (the "Definitive Agreement") pursuant to which PlantEXT and BB1 will effect a transaction that will result in a reverse...
2019-08-19 9:00 AM EDT
PlantEXT Engages Beacon Securities Limited for $7-Million USD Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - July 10, 2019) - PlantEXT Ltd. ("PlantEXT" or the "Company") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1") are pleased to announce that PlantEXT, a leader in the development and commercialization of pharmaceutical cannabis formulations for the treatment of inflammation related medical conditions, has entered into an engagement letter with Beacon Securities Limited ("Beacon") to conduct a brokered private placement of ordinary shares (each an "Offered...
2019-07-10 12:01 AM EDT
PlantEXT and Family Secret Execute Joint Venture Agreement to Develop, Produce and Market Topical Medical Cannabis Products
Toronto, Ontario--(Newsfile Corp. - April 29, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1") are pleased to announce that PlantEXT, a leader in the development and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions, has entered into a joint venture agreement (the "JV") with Family Secret Ltd. ("Family Secret") an established, Israeli formulation developer and manufacturer of all-natural medical...
2019-04-29 12:01 AM EDT
PlantEXT and Israel's Agricultural Research Organization Report Progress on Research and Development of Medical Cannabis Formulations for Inflammatory Bowel Disease
Toronto, Ontario--(Newsfile Corp. - April 11, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1") are pleased to announce that following more than three years of dedicated research in the laboratory of Prof. Hinanit Koltai, Agricultural Research Organization ("ARO"), PlantEXT and the State of Israel's ARO, have successfully refined earlier discoveries to develop active, anti-inflammatory formulations of cannabinoids and terpenes derived from cannabis. In vitro...
2019-04-11 12:01 AM EDT
Israeli Cabinet Approves Export of Medical Cannabis
Toronto, Ontario--(Newsfile Corp. - January 28, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) are pleased to announce that the Israeli Government's Cabinet has approved export of medical cannabis products. Exports are expected to begin after regulations are written, likely within the next 9-12 months.According to Doug Sommerville, CEO of PlantEXT, "The approval of medical cannabis exports from Israel is exciting news for the Israeli medical cannabis industry. The...
2019-01-28 10:28 AM EST
Plantext Ltd. and BB1 Acquisition Corp. Announce Letter of Intent for a Proposed Qualifying Transaction
Toronto, Ontario--(Newsfile Corp. - January 24, 2019) - Plantext Ltd. ("Plantext") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1" or the "Company") are pleased to announce the entering into of a binding Letter of Intent (the "LOI"), which sets forth the general terms and conditions pursuant to which Plantext and BB1 have agreed to complete a transaction (the "Transaction") that will result in a reverse take-over of BB1 by the shareholders of Plantext. It is intended that the Transaction will...
2019-01-24 6:24 PM EST
BB1 Acquisition Corp. Closes its Initial Public Offering
Toronto, Ontario--(Newsfile Corp. - November 30, 2018) - BB1 Acquisition Corp. (TSXV: BBA.P) (the "Corporation") is pleased to announce that it has completed an initial public offering of 5,000,000 common shares of the Corporation (the "Common Shares") at a price of $0.10 per Common Share for gross proceeds of $500,000 (the "Offering").Following the closing of the Offering, a total of 15,000,000 Common Shares are issued and outstanding, of which 10,100,000 are currently held in escrow...
2018-11-30 9:34 AM EST